(Nasdaq: PBM) ("Psyence Biomed" or the "Company") today announced the favorable outcome ... There are numerous risks and uncertainties that may cause actual results or performance to be materially ...
During the Company’s, Psyence Biomed presented a comprehensive plan to regain and maintain compliance with Nasdaq’s continued listing requirements, including 5550 (a) (2), the $1 minimum bid price ...
Psyence Biomedical Ltd. (Nasdaq: PBM) ("Psyence Biomed" or the "Company") today announced an effective date for its previously-announced share consolidation.
Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed” or the “Company”) today announced an effective date for its previously-announced share consolidation. At its Annual General and Special Meeting ...
All flight operations are currently normal. Check airline for updates. Nov 17, 2024 23:59 Zee Entertainment Raises Targets for CEO Punit Goenka Zee Entertainment's board has set higher performance ...
Congress is facing pressure from outside groups to consider legislation to reform the pharmacy benefit manager (PBM) industry during the lame duck period. PBM reforms have bipartisan backing ...